The DOI matches its Crossref record; 201 of the 201 references it cites were found in a registry or an index.
Post-stroke depression: Mechanisms and pharmacological treatment
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tarver, T. (2014) · Journal of Consumer Health On the Internet · doi:10.1080/15398285.2014.902284 · Cited by 5,605
Heart Disease and Stroke Statistics—2014 Update: A Report From the American Heart Association
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Blaha, M. J., Dai, S., Ford, E. S., Fox, C. S., Franco, S., et al. (2014) · Circulation · doi:10.1161/01.cir.0000441139.02102.80 · Cited by 5,215
Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321
Feigin, V. L., Forouzanfar, M. H., Krishnamurthi, R., Mensah, G. A., Connor, M., Bennett, D. A., Moran, A. E., Sacco, R. L., Anderson, L., Truelsen, T., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61953-4 · Cited by 3,899
O'Donnell, M. J., Xavier, D., Liu, L., Zhang, H., Chin, S. L., Rao-Melacini, P., Rangarajan, S., Islam, S., Pais, P., McQueen, M. J., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60834-3 · Cited by 3,448 · cited 1×
“Depression was one of the ten modifiable risk factors for stroke in the INTERSTROKE study in 22 countries with an OR of 1.35 (95% CI 1.10–1.66) (O'Donnell et al., 2010).”
BackgroundInfluentialWinstein, C. J., Stein, J., Arena, R., Bates, B., Cherney, L. R., Cramer, S. C., Deruyter, F., Eng, J. J., Fisher, B., Harvey, R. L., et al. (2016) · Stroke · doi:10.1161/str.0000000000000098 · Cited by 3,293
Heart disease and stroke statistics--2013 update: a report from the American Heart Association.
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Blaha, M. J., Dai, S., Ford, E. S., Fox, C. S., Franco, S., et al. (2013) · eScholarship (California Digital Library) · Cited by 2,601
The immunology of stroke: from mechanisms to translation
Iadecola, C., & Anrather, J. (2011) · Nature Medicine · doi:10.1038/nm.2399 · Cited by 2,596
Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654
Frequency of Depression After Stroke: A Systematic Review of Observational Studies
Hackett, M. L., Yapa, C., Parag, V., & Anderson, C. S. (2005) · Stroke · doi:10.1161/01.str.0000165928.19135.35 · Cited by 1,464
Neuroimaging studies of mood disorders
Drevets, W. C. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01020-9 · Cited by 1,313
Increased hippocampal bdnf immunoreactivity in subjects treated with antidepressant medication
Chen, B., Dowlatshahi, D., MacQueen, G. M., Wang, J.-F., & Young, L. T. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01083-6 · Cited by 1,164
Hackett, M. L., & Pickles, K. (2014) · International Journal of Stroke · doi:10.1111/ijs.12357 · Cited by 1,140
Post-Stroke Depression: A Review
Robinson, R. G., & Jorge, R. E. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15030363 · Cited by 1,125
MOOD DISORDERS IN STROKE PATIENTS: IMPORTANCE OF LOCATION OF LESION
ROBINSON, R. G., KUBOS, K. L., STARR, L. B., RAO, K., & PRICE, T. R. (1984) · Brain · doi:10.1093/brain/107.1.81 · Cited by 1,115
Oxidative stress in psychiatric disorders: evidence base and therapeutic implications
Ng, F., Berk, M., Dean, O., & Bush, A. I. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008401 · Cited by 1,069
Towards a glutamate hypothesis of depression
Sanacora, G., Treccani, G., & Popoli, M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.036 · Cited by 1,036
Ayerbe, L., Ayis, S., Wolfe, C. D. A., & Rudd, A. G. (2013) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.107664 · Cited by 980 · cited 1×
“According to the meta-analyses by Ayerbe et al. (2013) and Hackett and Pickles (2014) the prevalence rate was stable in the first year but declined thereafter.”
MethodOxidative Stress and Its Role in the Pathogenesis of Ischaemic Stroke
Allen, C. L., & Bayraktutan, U. (2009) · International Journal of Stroke · doi:10.1111/j.1747-4949.2009.00387.x · Cited by 966
Chollet, F., Tardy, J., Albucher, J.-F., Thalamas, C., Berard, E., Lamy, C., Bejot, Y., Deltour, S., Jaillard, A., Niclot, P., et al. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70314-8 · Cited by 925
The vascular depression hypothesis: mechanisms linking vascular disease with depression
Taylor, W. D., Aizenstein, H. J., & Alexopoulos, G. S. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.20 · Cited by 923
Hannestad, J., DellaGioia, N., & Bloch, M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.132 · Cited by 914
Penninx, B. W., Milaneschi, Y., Lamers, F., & Vogelzangs, N. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-129 · Cited by 839
Antidepressant use and risk of adverse outcomes in older people: population based cohort study
Coupland, C., Dhiman, P., Morriss, R., Arthur, A., Barton, G., & Hippisley-Cox, J. (2011) · BMJ · doi:10.1136/bmj.d4551 · Cited by 833
Depression and Risk of Stroke Morbidity and Mortality: A Meta-analysis and Systematic Review
Pan, A., Sun, Q., Okereke, O. I., Rexrode, K. M., & Hu, F. B. (2011) · JAMA · doi:10.1001/jama.2011.1282 · Cited by 819
Bidirectional Association Between Depression and Metabolic Syndrome
Pan, A., Keum, N., Okereke, O. I., Sun, Q., Kivimaki, M., Rubin, R. R., & Hu, F. B. (2012) · Diabetes Care · doi:10.2337/dc11-2055 · Cited by 772
Towfighi, A., Ovbiagele, B., El Husseini, N., Hackett, M. L., Jorge, R. E., Kissela, B. M., Mitchell, P. H., Skolarus, L. E., Whooley, M. A., & Williams, L. S. (2017) · Stroke · doi:10.1161/str.0000000000000113 · Cited by 769
Maes, M., Leonard, B. E., Myint, A. M., Kubera, M., & Verkerk, R. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.12.017 · Cited by 700
Stroke incidence and prevalence in Europe: a review of available data
Truelsen, T., Piechowski‐Jóźwiak, B., Bonita, R., Mathers, C., Bogousslavsky, J., & Boysen, G. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01138.x · Cited by 665
Kappelmann, N., Lewis, G., Dantzer, R., Jones, P. B., & Khandaker, G. M. (2018) · Molecular Psychiatry · doi:10.1038/mp.2016.167 · Cited by 659
Schmidt, H. D., & Duman, R. S. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282ee2aa8 · Cited by 648
Exaggerated platelet reactivity in major depression
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.10.1313 · Cited by 566
HPA Axis Reactivity: A Mechanism Underlying the Associations Among 5-HTTLPR, Stress, and Depression
Gotlib, I. H., Joormann, J., Minor, K. L., & Hallmayer, J. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.10.008 · Cited by 558
Meng, L., Chen, D., Yang, Y., Zheng, Y., & Hui, R. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e32835080b7 · Cited by 526
Inflammation in Depression and the Potential for Anti-Inflammatory Treatment
Kohler, O., Krogh, J., Mors, O., & Eriksen Benros, M. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666151208113700 · Cited by 516
Owens, M. J., Knight, D. L., & Nemeroff, C. B. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01145-3 · Cited by 516
Predictors of Depression after Stroke: A Systematic Review of Observational Studies
Hackett, M. L., & Anderson, C. S. (2005) · Stroke · doi:10.1161/01.str.0000183622.75135.a4 · Cited by 463
Poststroke depression: prevalence, diagnosis, treatment, and disease progression
Robinson, R. G. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00423-2 · Cited by 460
Mitochondrial Dysfunction and Psychiatric Disorders
Rezin, G. T., Amboni, G., Zugno, A. I., Quevedo, J., & Streck, E. L. (2009) · Neurochemical Research · doi:10.1007/s11064-008-9865-8 · Cited by 442
Mitchell, A. J., Sheth, B., Gill, J., Yadegarfar, M., Stubbs, B., Yadegarfar, M., & Meader, N. (2017) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2017.04.001 · Cited by 414
Kutlubaev, M. A., & Hackett, M. L. (2014) · International Journal of Stroke · doi:10.1111/ijs.12356 · Cited by 407
Choi, S.-H., Aid, S., & Bosetti, F. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.01.002 · Cited by 402
Acid sphingomyelinase–ceramide system mediates effects of antidepressant drugs
Gulbins, E., Palmada, M., Reichel, M., Lüth, A., Böhmer, C., Amato, D., Müller, C. P., Tischbirek, C. H., Groemer, T. W., Tabatabai, G., et al. (2013) · Nature Medicine · doi:10.1038/nm.3214 · Cited by 384
Robinson, R. G., Jorge, R. E., Moser, D. J., Acion, L., Solodkin, A., Small, S. L., Fonzetti, P., Hegel, M., & Arndt, S. (2008) · JAMA · doi:10.1001/jama.299.20.2391 · Cited by 355
Mitochondrial Dysfunction in Depression
Bansal, Y., & Kuhad, A. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160229114755 · Cited by 353
Gardner, A., & Boles, R. G. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.030 · Cited by 333
Depression and Risk of Stroke: A Meta-Analysis of Prospective Studies
Dong, J.-Y., Zhang, Y.-H., Tong, J., & Qin, L.-Q. (2012) · Stroke · doi:10.1161/strokeaha.111.630871 · Cited by 327
Vogelzangs, N., Duivis, H. E., Beekman, A. T. F., Kluft, C., Neuteboom, J., Hoogendijk, W., Smit, J. H., de Jonge, P., & Penninx, B. W. J. H. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.8 · Cited by 323 · cited 1×
“However, SSRIs (but not other antidepressants) display anti-inflammatory effects in non-stroke depressed patients (meta-analyses by Hannestad et al., 2011; Vogelzangs et al., 2012).”
BackgroundSystemic infection, inflammation and acute ischemic stroke
McColl, B. W., Allan, S. M., & Rothwell, N. J. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.08.019 · Cited by 318
Post‐stroke depression: mechanisms, translation and therapy
Loubinoux, I., Kronenberg, G., Endres, M., Schumann‐Bard, P., Freret, T., Filipkowski, R. K., Kaczmarek, L., & Popa‐Wagner, A. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2012.01555.x · Cited by 315
Papakostas, G. I., Thase, M. E., Fava, M., Nelson, J. C., & Shelton, R. C. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.03.027 · Cited by 308
Cytokines mediated inflammation and decreased neurogenesis in animal models of depression
Song, C., & Wang, H. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.06.020 · Cited by 291
Spalletta, G., Bossù, P., Ciaramella, A., Bria, P., Caltagirone, C., & Robinson, R. G. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001879 · Cited by 290
Depression after Stroke and Risk of Mortality: A Systematic Review and Meta-Analysis
Bartoli, F., Lillia, N., Lax, A., Crocamo, C., Mantero, V., Carrà, G., Agostoni, E., & Clerici, M. (2013) · Stroke Research and Treatment · doi:10.1155/2013/862978 · Cited by 273
Risk Factors for Post-stroke Depression: A Meta-analysis
Shi, Y., Yang, D., Zeng, Y., & Wu, W. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00218 · Cited by 271
Masi, G., & Brovedani, P. (2011) · CNS Drugs · doi:10.2165/11595900-000000000-00000 · Cited by 260
Sauer, W. H., Berlin, J. A., & Kimmel, S. E. (2003) · Circulation · doi:10.1161/01.cir.0000079172.43229.cd · Cited by 247
Fluoxetine affords robust neuroprotection in the postischemic brain via its anti‐inflammatory effect
Lim, C., Kim, S., Park, J., Kim, C., Yoon, S. H., & Lee, J. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.21899 · Cited by 244
Neuroprotection for ischaemic stroke: Current status and challenges
Moretti, A., Ferrari, F., & Villa, R. F. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.09.003 · Cited by 240
Self-citationEpidemiology and treatment of post-stroke depression
Paolucci, S. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s2017 · Cited by 237
Depressive Symptoms and Risk of Stroke: The Framingham Study
Salaycik, K. J., Kelly-Hayes, M., Beiser, A., Nguyen, A.-H., Brady, S. M., Kase, C. S., & Wolf, P. A. (2007) · Stroke · doi:10.1161/01.str.0000251695.39877.ca · Cited by 231
Selective serotonin reuptake inhibitors and brain hemorrhage: A meta-analysis
Hackam, D. G., & Mrkobrada, M. (2012) · Neurology · doi:10.1212/wnl.0b013e318271f848 · Cited by 230
(1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.8.937 · Cited by 225
Prevalence of Stroke and Stroke-Related Disability: Estimates From the Auckland Stroke Studies
Bonita, R., Solomon, N., & Broad, J. B. (1997) · Stroke · doi:10.1161/01.str.28.10.1898 · Cited by 224
Escitalopram and Enhancement of Cognitive Recovery Following Stroke
Jorge, R. E., Acion, L., Moser, D., Adams, H. P., & Robinson, R. G. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.185 · Cited by 218
Narushima, K. (2003) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.15.4.422 · Cited by 216
Increased Cytokine Release from Peripheral Blood Cells after Acute Stroke
Ferrarese, C., Mascarucci, P., Zoia, C., Cavarretta, R., Frigo, M., Begni, B., Sarinella, F., Frattola, L., & De Simoni, M. G. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199909000-00008 · Cited by 209
Quinn, T., Paolucci, S., Sunnerhagen, K., Sivenius, J., Walker, M., Toni, D., Lees, K., & The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee (2009) · Journal of Rehabilitation Medicine · doi:10.2340/16501977-0301 · Cited by 201
Kölzer, M., Werth, N., & Sandhoff, K. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00033-x · Cited by 198
Post-stroke depression and lesion location: a systematic review
Wei, N., Yong, W., Li, X., Zhou, Y., Deng, M., Zhu, H., & Jin, H. (2015) · Journal of Neurology · doi:10.1007/s00415-014-7534-1 · Cited by 194
The Neurobiology of Depression: an Integrated Overview from Biological Theories to Clinical Evidence
Ferrari, F., & Villa, R. F. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0032-y · Cited by 186
Self-citationPsychological distress, major depressive disorder, and risk of stroke
Surtees, P. G., Wainwright, N. W. J., Luben, R. N., Wareham, N. J., Bingham, S. A., & Khaw, K.-T. (2008) · Neurology · doi:10.1212/01.wnl.0000304109.18563.81 · Cited by 183 · cited 1×
“For example, Surtees et al. (2008) noted a significant association between psychological distress (but not major depressive disorder) and stroke.”
BackgroundAssessment of Depression After Stroke: A Comparison of Different Screening Instruments
Berg, A., Lönnqvist, J., Palomäki, H., & Kaste, M. (2009) · Stroke · doi:10.1161/strokeaha.108.527705 · Cited by 177
Na, K.-S., Lee, K. J., Lee, J. S., Cho, Y. S., & Jung, H.-Y. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.09.006 · Cited by 176
The long-term outcomes of depression up to 10 years after stroke; the South London Stroke Register
Ayerbe, L., Ayis, S., Crichton, S., Wolfe, C. D. A., & Rudd, A. G. (2014) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-306448 · Cited by 176
Xu, H., Steven Richardson, J., & Li, X.-M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300009 · Cited by 167
De Ryck, A., Brouns, R., Geurden, M., Elseviers, M., De Deyn, P. P., & Engelborghs, S. (2014) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988714527514 · Cited by 167
Jiang, X., Huang, J., Song, D., Deng, R., Wei, J., & Zhang, Z. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00018 · Cited by 165
A mitochondrial bioenergetic basis of depression
Klinedinst, N. J., & Regenold, W. T. (2014) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-014-9584-6 · Cited by 163
JNK3 Signaling Pathway Activates Ceramide Synthase Leading to Mitochondrial Dysfunction
Yu, J., Novgorodov, S. A., Chudakova, D., Zhu, H., Bielawska, A., Bielawski, J., Obeid, L. M., Kindy, M. S., & Gudz, T. I. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701812200 · Cited by 159
Cortisol levels and the severity and outcomes of acute stroke: a systematic review
Barugh, A., Gray, P., Shenkin, S. D., MacLullich, A. M. J., & Mead, G. E. (2014) · Journal of Neurology · doi:10.1007/s00415-013-7231-5 · Cited by 157
Acler, M., Robol, E., Fiaschi, A., & Manganotti, P. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5093-7 · Cited by 139
Li, W., Cai, H., Wang, B., Chen, L., Zhou, Q., Luo, C., Liu, N., Ding, X., & Zhu, D. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21829 · Cited by 137
Inhibitors of the sphingomyelin cycle: Sphingomyelin synthases and sphingomyelinases
Adada, M. M., Luberto, C., & Canals, D. (2015) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2015.07.008 · Cited by 133
Brain-Derived Neurotrophic Factor Stimulates Energy Metabolism in Developing Cortical Neurons
Burkhalter, J., Fiumelli, H., Allaman, I., Chatton, J., & Martin, J. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-23-08212.2003 · Cited by 133
Treatment Effects of Antidepressants in Patients with Post-Stroke Depression: A Meta-Analysis
Chen, Y., Guo, J. J., Zhan, S., & Patel, N. C. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1h389 · Cited by 126
Affective disorders, antidepressant drugs and brain metabolism
Moretti, A., Gorini, A., & Villa, R. F. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001353 · Cited by 123
Self-citationSelective Serotonin Reuptake Inhibitors for Stroke Recovery: A Systematic Review and Meta-analysis
Mead, G. E., Hsieh, C., Lee, R., Kutlubaev, M. A., Claxton, A., Hankey, G. J., & Hackett, M. L. (2013) · Stroke · doi:10.1161/strokeaha.112.673947 · Cited by 121
Social isolation after stroke leads to depressive-like behavior and decreased BDNF levels in mice
O’Keefe, L. M., Doran, S. J., Mwilambwe-Tshilobo, L., Conti, L. H., Venna, V. R., & McCullough, L. D. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.10.047 · Cited by 119
Kim, J. S., Lee, E.-J., Chang, D.-I., Park, J. H., Sj, A., Jk, C., Heo, J. H., Sohn, S.-I., Lee, B., Kim, H. Y., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30417-5 · Cited by 117
Advances in antidepressants for treating post-stroke depression
Paolucci, S. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1334765 · Cited by 114
Depression and Stroke: Cause or Consequence?
Williams, L. S. (2005) · Seminars in Neurology · doi:10.1055/s-2005-923534 · Cited by 112
Depression and Incident Stroke in Women
Pan, A., Okereke, O. I., Sun, Q., Logroscino, G., Manson, J. E., Willett, W. C., Ascherio, A., Hu, F. B., & Rexrode, K. M. (2011) · Stroke · doi:10.1161/strokeaha.111.617043 · Cited by 111
Terroni, L. D. M. N., Amaro, E., Iosifescu, D. V., Tinone, G., Sato, J. R., Leite, C. C., Sobreiro, M. D. F. M., de Lúcia, M. C. S., Scaff, M., & Fráguas, R. (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.562242 · Cited by 110
Serum Brain-derived neurotrophic factor levels in post-stroke depression
Li, J., Zhao, Y.-D., Zeng, J., Chen, X.-Y., Wang, R.-D., & Cheng, S. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.07.011 · Cited by 108
Effect of Antidepressants on the Course of Disability Following Stroke
Mikami, K., Jorge, R. E., Adams, H. P., Davis, P. H., Leira, E. C. C., Jang, M., & Robinson, R. G. (2011) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e31821181b0 · Cited by 104
A central role for the acid sphingomyelinase/ceramide system in neurogenesis and major depression
Gulbins, E., Walter, S., Becker, K. A., Halmer, R., Liu, Y., Reichel, M., Edwards, M. J., Müller, C. P., Fassbender, K. C., & Kornhuber, J. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13145 · Cited by 103
The neuroanatomical model of post-stroke depression: Towards a change of focus?
Santos, M., Kövari, E., Gold, G., Bozikas, V. P., Hof, P. R., Bouras, C., & Giannakopoulos, P. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.02.334 · Cited by 102
Multinuclear Magnetic Resonance Spectroscopy Studies of Brain Purines in Major Depression
Renshaw, P. F., Parow, A. M., Hirashima, F., Ke, Y., Moore, C. M., Frederick, B. D., Fava, M., Hennen, J., & Cohen, B. M. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.2048 · Cited by 101
Prevention and Treatment of Poststroke Depression With Mirtazapine in Patients With Acute Stroke
Niedermaier, N., Bohrer, E., Schulte, K., Schlattmann, P., & Heuser, I. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1206 · Cited by 99
Low serum BDNF may indicate the development of PSD in patients with acute ischemic stroke
Yang, L., Zhang, Z., Sun, D., Xu, Z., Yuan, Y., Zhang, X., & Li, L. (2010) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2552 · Cited by 98
Shin, D., Oh, Y. H., Eom, C.-S., & Park, S. M. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7251-9 · Cited by 98
Siepmann, T., Penzlin, A. I., Kepplinger, J., Illigens, B. M. W., Weidner, K., Reichmann, H., & Barlinn, K. (2015) · Brain and Behavior · doi:10.1002/brb3.373 · Cited by 96
Social Stress Exacerbates Focal Cerebral Ischemia in Mice
Sugo, N., Hurn, P. D., Morahan, M., Hattori, K., Traystman, R. J., & DeVries, A. C. (2002) · Stroke · doi:10.1161/01.str.0000016967.76805.bf · Cited by 96
Lee, C. H., Park, J. H., Yoo, K., Choi, J. H., Hwang, I. K., Ryu, P. D., Kim, D., Kwon, Y., Kim, Y., & Won, M. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.03.015 · Cited by 96
Brunner, E. J., Shipley, M. J., Britton, A. R., Stansfeld, S. A., Heuschmann, P. U., Rudd, A. G., Wolfe, C. D. A., Singh‐Manoux, A., & Mika Kivimaki, B. (2014) · European Journal of Preventive Cardiology · doi:10.1177/2047487314520785 · Cited by 94
Prevention of Poststroke Depression: Does Prophylactic Pharmacotherapy Work?
Salter, K. L., Foley, N. C., Zhu, L., Jutai, J. W., & Teasell, R. W. (2012) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2012.03.013 · Cited by 93
Li, W., Ling, S., Yang, Y., Hu, Z., Davies, H., & Fang, M. (2014) · PubMed · Cited by 93
The serum interleukin-18 is a potential marker for development of post-stroke depression
Yang, L., Zhang, Z., Sun, D., Xu, Z., Zhang, X., & Li, L. (2010) · Neurological Research · doi:10.1179/016164110x12656393665080 · Cited by 92
A Prospective Study on the Prevalence and Risk Factors of Poststroke Depression
Ryck, A. D., Brouns, R., Fransén, E., Geurden, M., Gestel, G. V., Wilssens, I., Ceulaer, L. D., Mariën, P., Deyn, P. P. D., & Engelborghs, S. (2013) · Cerebrovascular Diseases Extra · doi:10.1159/000345557 · Cited by 91
Antidepressant prophylaxis for poststroke depression: a meta-analysis
Chen, Y., Patel, N. C., Guo, J. J., & Zhan, S. (2007) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32807fb028 · Cited by 89
Wang, S., Zhang, Z., Guo, Y., Teng, G., & Chen, B. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.11.028 · Cited by 89
Reduction of CSF monoamine metabolites in poststroke depression: a preliminary report
Bryer, J. B., STARKSTEIN, S. E., Votypka, V., Parikh, R. M., Price, T. R., & Robinson, R. G. (1992) · Journal of Neuropsychiatry · doi:10.1176/jnp.4.4.440 · Cited by 87
Symptom Profile of DSM-IV Major and Minor Depressive Disorders in First-Ever Stroke Patients
Spalletta, G., Ripa, A., & Caltagirone, C. (2005) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200502000-00004 · Cited by 87
Flaster, M. S., Sharma, A., & Rao, M. S. (2013) · Topics in Stroke Rehabilitation · doi:10.1310/tsr2002-139 · Cited by 85
Fluoxetine and recovery of motor function after focal ischemia in rats
Windle, V., & Corbett, D. (2005) · Brain Research · doi:10.1016/j.brainres.2005.02.060 · Cited by 85
Sibolt, G., Curtze, S., Melkas, S., Pohjasvaara, T., Kaste, M., Karhunen, P. J., Oksala, N., Vataja, R., & Erkinjuntti, T. (2013) · Cerebrovascular Diseases · doi:10.1159/000355145 · Cited by 83
Mortensen, J. K., Larsson, H. J., Johnsen, S. P., & Andersen, G. (2013) · Stroke · doi:10.1161/strokeaha.112.674242 · Cited by 82
Depression and Risk of Stroke in Midaged Women: A Prospective Longitudinal Study
Jackson, C., & Mishra, G. D. (2013) · Stroke · doi:10.1161/strokeaha.113.001147 · Cited by 82
Of mice and men: modelling post‐stroke depression experimentally
Kronenberg, G., Gertz, K. R., Heinz, A., & Endres, M. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12775 · Cited by 81
Single voxel proton magnetic resonance spectroscopy in post-stroke depression
Głodzik-Sobańska, L., Słowik, A., McHugh, P. F., Sobiecka, B., Kozub, J., Rich, K. E., Urbanik, A., & Szczudlik, A. (2006) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2006.08.004 · Cited by 81
Aström, M., Olsson, T., & Asplund, K. (1993) · Stroke · doi:10.1161/01.str.24.1.52 · Cited by 80
Clinical pharmacology review of escitalopram for the treatment of depression
Pastoor, D., & Gobburu, J. V. S. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.863873 · Cited by 80
Depressive symptoms and risk of stroke: the Rotterdam Study
Bos, M. J., Linden, T. K. A., Koudstaal, P. J., Albert Hofman, D., Skoog, I. G., Breteler, M. M. B., & Tiemeier, H. W. (2008) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.134965 · Cited by 80
McCann, S., Irvine, C., Mead, G. E., Sena, E. S., Currie, G. L., Egan, K. J., Macleod, M. R., & Howells, D. W. (2014) · Stroke · doi:10.1161/strokeaha.114.006304 · Cited by 78
Plasma levels of glutamate during stroke is associated with development of post-stroke depression
Cheng, S., Zhao, Y.-D., Li, J., Chen, X.-Y., Wang, R.-D., & Zeng, J. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.05.006 · Cited by 77
Post-stroke and vascular depression: a critical review
Provinciali, L., & Coccia, M. (2002) · Neurological Sciences · doi:10.1007/s100720200000 · Cited by 75
Serotonergic and BDNF genes and risk of depression after stroke
Kim, J., Stewart, R. J., Bae, K., Kim, S., Kang, H., Shin, I., Kim, J., Park, M., Kim, M.-K., Park, S., et al. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.09.029 · Cited by 75
Polymorphisms of the serotonin transporter gene and post-stroke depression: a meta-analysis
Mak, K. K., Kong, W. Y., Mak, A., Sharma, V. K., & Ho, R. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303791 · Cited by 74
Swenson, J. R., Doucette, S. P., & Fergusson, D. A. (2006) · The Canadian Journal of Psychiatry · doi:10.1177/070674370605101408 · Cited by 71
Efficacy and feasibility of antidepressant treatment in patients with post-stroke depression
Xu, X., Zou, D., Shen, L.-Y., Liu, Y., Zhou, X., Pu, J., Dong, M.-X., & Wei, Y.-D. (2016) · Medicine · doi:10.1097/md.0000000000005349 · Cited by 71
Changes in Depressive Symptoms and Incidence of First Stroke Among Middle‐Aged and Older US Adults
Gilsanz, P., Walter, S., Tchetgen, E. J. T., Patton, K. K., Moon, J. R., Capistrant, B. D., Marden, J. R., Kubzansky, L. D., Kawachi, I. I., & Glymour, M. M. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.001923 · Cited by 70
Noonan, K., Carey, L. M., & Crewther, S. G. (2012) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2012.09.008 · Cited by 67
Tissue Type-Specific Bioenergetic Abnormalities in Adults with Major Depression
Harper, D. G., Jensen, J. E., Ravichandran, C. T., Perlis, R. H., D, M. F. M., Renshaw, P. F., & Iosifescu, D. V. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.180 · Cited by 67
Biffi, A., Scotti, L., & Corrao, G. (2017) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-016-2187-x · Cited by 67
Fu, X., Chen, H., Zhang, N., Li, W.-Y., Fang, M., Zhang, H., Fang, Y., & Ding, M. (2015) · Neural Regeneration Research · doi:10.4103/1673-5374.165510 · Cited by 66
Espinera, A. R., Ogle, M. E., Gu, X., & Li, W. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.011 · Cited by 63
Neuropsychiatric Symptoms and Interleukin-6 Serum Levels in Acute Stroke
Spalletta, G., Cravello, L., Imperiale, F., Salani, F., Bossù, P., Picchetto, L., Cao, M., Rasura, M., Pazzelli, F., Orzi, F., et al. (2013) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.12120399 · Cited by 63
Fluoxetine for the prophylaxis of poststroke depression in patients with stroke: a meta-analysis
Yi, Z., Liu, F., & Zhai, S. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02437.x · Cited by 62
Fluoxetine and Sertraline Attenuate Postischemic Brain Injury in Mice
Shin, T. K., Kang, M. S., Lee, H. Y., Seo, M. S., Kim, S. G., Kim, C. D., & Lee, W. S. (2009) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2009.13.3.257 · Cited by 62
Antidepressant Action on Mitochondrial Dysfunction in Psychiatric Disorders
Adzic, M., Brkic, Z., Bulajic, S., Mitic, M., & Radojcic, M. B. (2016) · Drug Development Research · doi:10.1002/ddr.21332 · Cited by 60
Villa, R. F., Ferrari, F., Bagini, L., Gorini, A., Brunello, N., & Tascedda, F. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.04.025 · Cited by 60
Self-citationHusaini, B. A., Levine, R. S., Sharp, L., Cain, V. A., Novotny, M. L., Hull, P. C., Orum, G., Samad, Z., Sampson, U. K. A., & Moonis, M. (2013) · Stroke Research and Treatment · doi:10.1155/2013/846732 · Cited by 59
Endocrine regulation of neurotransmitter transporters
Figlewicz, D. P. (1999) · Epilepsy Research · doi:10.1016/s0920-1211(99)00072-8 · Cited by 58
Neuroprotective Therapy for Stroke and Ischemic Disease
Zhang, J. H., & Lapchak, P. A. (2017) · Springer series in translational stroke research · doi:10.1007/978-3-319-45345-3 · Cited by 53
Kappelmann, N., Lewis, G., Dantzer, R., Jones, P. B., & Khandaker, G. M. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.07.023 · Cited by 51
Majed, B., Arveiler, D., Bingham, A., Ferrières, J., Ruidavets, J., Montaye, M., Appleton, K. M., Haas, B., Kee, F., Amouyel, P., et al. (2012) · Stroke · doi:10.1161/strokeaha.111.645366 · Cited by 50
Effect of desipramine and fluoxetine on energy metabolism of cerebral mitochondria
Villa, R. F., Ferrari, F., Gorini, A., Brunello, N., & Tascedda, F. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.05.051 · Cited by 50
Self-citationPharmacological therapy of acute ischaemic stroke: Achievements and problems
Moretti, A., Ferrari, F., & Villa, R. F. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.06.004 · Cited by 49
Self-citationBaune, B. T. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_19 · Cited by 49
Ried, L. D., Jia, H., Feng, H., Cameon, R., Wang, X., Tueth, M. J., & Wu, S. S. (2011) · Annals of Pharmacotherapy · doi:10.1345/aph.1p478 · Cited by 47
Therapy for prevention of post-stroke depression
Ramasubbu, R. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.596149 · Cited by 47
Filipović, D., Costina, V., Perić, I., Stanisavljević, A., & Findeisen, P. (2017) · Brain Research · doi:10.1016/j.brainres.2017.01.025 · Cited by 46
Sun, J., Ma, H., Yu, C., Lv, J., Guo, Y., Bian, Z., Yang, L., Chen, Y., Shen, H., Chen, Z., et al. (2016) · Stroke · doi:10.1161/strokeaha.116.013512 · Cited by 45
Depression Is Associated with a Higher Risk of Death among Stroke Survivors
Razmara, A., Valle, N. P., Markovic, D., Sanossian, N., Ovbiagele, B., Dutta, T. M., & Towfighi, A. (2017) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2017.07.006 · Cited by 45
Lee, Y., Lin, C., Lin, M.-S., Lin, J., Chang, C., & Lai, M. (2013) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31829c970e · Cited by 44
Villa, R. F., Gorini, A., Ferrari, F., & Hoyer, S. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.10.004 · Cited by 44
Self-citationA Two-Phase Pathogenetic Model of Depression after Stroke
Werheid, K. (2015) · Gerontology · doi:10.1159/000381876 · Cited by 43
Functional Inhibitors of Acid Sphingomyelinase (FIASMAs)
Kornhuber, J., Tripal, P., Gulbins, E., & Muehlbacher, M. (2013) · Handbook of experimental pharmacology · doi:10.1007/978-3-7091-1368-4_9 · Cited by 43
Prevention of poststroke depression with milnacipran in patients with acute ischemic stroke
Tsai, C., Wu, C.-L., Chou, S., Tsang, H., Hung, T., & Su, J. (2011) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32834a5c64 · Cited by 43
Nguyen, V., Carey, L. M., Giummarra, L., Faou, P., Cooke, I., Howells, D. W., Tse, T., Macaulay, S. L., Ma, H., Davis, S. M., et al. (2016) · Frontiers in Neurology · doi:10.3389/fneur.2016.00085 · Cited by 43
The Behavioral Consequences of Stroke
Schweizer, T. A., & Macdonald, R. L. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7672-6 · Cited by 43
Decreased Heart Rate Variability is Associated with Poststroke Depression
Robinson, R. G., Spalletta, G., Jorge, R. E., Bassi, A., Colivicchi, F., Ripa, A., & Caltagirone, C. (2008) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e318180057d · Cited by 42
Serum interleukin-6 predicts cortisol release in acute stroke patients
Szczudlik, A., Dziedzic, T., Bartuś, S., Słowik, A., & Kiełtyka, A. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03350908 · Cited by 42
Zhang, Z., Wu, L., Song, J., & Li, W. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.1009 · Cited by 42
Mortensen, J. K., Larsson, H. J., Johnsen, S. P., & Andersen, G. (2014) · Stroke · doi:10.1161/strokeaha.114.005302 · Cited by 41
Gao, J., Lin, M., Zhao, J., Bi, S., Ni, Z., & Shang, X. (2016) · Clinical Rehabilitation · doi:10.1177/0269215515626232 · Cited by 40
Serotonin 5HT1Areceptor availability and pathological crying after stroke
Møller, M., Andersen, G., & GJEDDE, A. H. (2007) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2007.00869.x · Cited by 37
Gaynor, P. J., Gopal, M., Zheng, W., Martinez, J. M., Robinson, M. J., & Marangell, L. B. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.609539 · Cited by 37
Prophylactic Effects of Duloxetine on Post-Stroke Depression Symptoms: An Open Single-Blind Trial
Zhang, L., Hu, X., Yao, L.-Y., Geng, Y., Wei, L.-L., Zhang, J., & Chen, W. (2013) · European Neurology · doi:10.1159/000345374 · Cited by 37
Stereoselective Metabolism of Citalopram in Plasma and Cerebrospinal Fluid of Depressive Patients
Nikisch, G., Mathé, A. A., Czernik, A., Eap, C. B., Jiménez-Vasquez, P. A., Brawand-Amey, M., & Baumann, P. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000125680.89843.a6 · Cited by 36
Depressive Symptoms and the Risk of Ischemic Stroke in the Elderly—Influence of Age and Sex
Seifert, C. L., Poppert, H., Sander, D., Feurer, R., Etgen, T., Ander, K., Pürner, K., Brönner, M., Sepp, D., Kehl, V., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050803 · Cited by 36
Wang, S., Zhang, Z., Guo, Y., Sui, Y., & Sun, Y. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.12.017 · Cited by 36
Mood Disorders after Stroke: Diagnostic Validation of the Poststroke Depression Rating Scale
Quaranta, D., Marra, C., & Gainotti, G. (2008) · Cerebrovascular Diseases · doi:10.1159/000147450 · Cited by 36
Psychological services for people with stroke: compliance with the UK National Clinical Guidelines
Bowen, A., Knapp, P., Hoffman, A., & Lowe, D. (2005) · Clinical Rehabilitation · doi:10.1191/0269215505cr799oa · Cited by 35
Hoirisch-Clapauch, S., Nardi, A. E., Gris, J., & Brenner, B. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.02.028 · Cited by 33
Role of hypothalamic cannabinoid receptors in post-stroke depression in rats
Wang, S., Sun, H., Liu, S., Wang, T., Guan, J.-Q., & Jia, J. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.01.006 · Cited by 33
Energy metabolism of rat cerebral cortex, hypothalamus and hypophysis during ageing
Villa, R. F., Ferrari, F., & Gorini, A. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.09.041 · Cited by 32
Self-citationEarly Depression Screening Is Feasible in Hospitalized Stroke Patients
Karamchandani, R. R., Vahidy, F., Bajgur, S. S., Vu, K. Y. T., Choi, H. A., Hamilton, R., Rahbar, M. H., & Savitz, S. I. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128246 · Cited by 31
Studies on the animal model of post-stroke depression and application of antipsychotic aripiprazole
Kim, Y. R., Kim, H. N., Pak, M. E., Ahn, S., Hong, K. H., Shin, H. K., & Choi, B. T. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.03.062 · Cited by 31
Biomarkers in Post-stroke Depression
Pedroso, V. S. P., Rachid, M. A., & Teixeira, A. L. (2016) · Current Neurovascular Research · doi:10.2174/1567202613666160219120114 · Cited by 29
Safety of selective serotonin reuptake inhibitor treatment in recovering stroke patients
Mortensen, J. K., & Andersen, G. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.1033396 · Cited by 28
Depression, stroke and gender: evidence of a stronger association in men
Hamano, T., Li, X., Lönn, S. L., Nabika, T., Shiwaku, K., Sundquist, J., & Sundquist, K. (2014) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-307616 · Cited by 27
Early Antidepressant Treatment and All-Cause 30-Day Mortality in Patients with Ischemic Stroke
Mortensen, J. K., Johnsen, S. P., Larsson, H. J., & Andersen, G. (2015) · Cerebrovascular Diseases · doi:10.1159/000435819 · Cited by 21
Sun, X., Zhou, Z., Liu, T., Zhao, M., Zhao, S., Xiao, T., Jolkkonen, J., & Zhao, C. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0662-y · Cited by 20
Does Prestroke Depression Impact Poststroke Depression and Treatment?
Ried, L. D., Jia, H., Cameon, R., Feng, H., Wang, X., & Tueth, M. J. (2010) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181ca822b · Cited by 19
Vascular depression: where do we go from here?
Naarding, P., & Beekman, A. T. F. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.92 · Cited by 19
Siepmann, T., Kepplinger, J., Zerna, C., Schatz, U., Penzlin, A. I., Pallesen, L., Illigens, B. M. W., Weidner, K., Reichmann, H., Puetz, V., et al. (2015) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2015.04.033 · Cited by 19
Lee, Y., Lin, C., Lin, M.-S., Lu, Y., Chang, C., & Lin, J. (2016) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09394 · Cited by 19
Paulzen, M., Lammertz, S. E., Gründer, G., Veselinović, T., Hiemke, C., & Tauber, S. C. (2015) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000114 · Cited by 19
Zhao, Q., Guo, Y., Yang, D. W., Yang, T., & Meng, X. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9120-7 · Cited by 17
Miedema, I., Horváth, K., Uyttenboogaart, M., Koopman, K., Lahr, M. M. H., Keyser, J. D., & Luijckx, G. J. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.03.004 · Cited by 12
Selim, M. H., & Molina, C. A. (2012) · Stroke · doi:10.1161/strokeaha.112.657635 · Cited by 11
Antidepressants in the treatment of stroke
Burns, M. M. J., & Greenberg, D. A. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.96 · Cited by 10
A Macro Role for Microglia in Poststroke Depression
Jawaid, A., Krajewska, J. B., Pawliczak, F., Kandra, V., & Schulz, P. E. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13974 · Cited by 8
Should Every Patient With Stroke Be on Selective Serotonin Reuptake Inhibitors?
Marshall, R. S. (2012) · Stroke · doi:10.1161/strokeaha.112.657627 · Cited by 6
Neuroprotective effect of escitalopram oxalate in rats with chronic hypoperfusion
Ma, L., Lu, Z., Hu, P. L., & Yao, C. (2015) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-015-1462-x · Cited by 6
Effects of Neuroprotectants Before and After Stroke: Statins and Anti-hypertensives
Villa, R. F., Ferrari, F., & Moretti, A. (2017) · Springer series in translational stroke research · doi:10.1007/978-3-319-45345-3_14 · Cited by 5
Self-citationSelective Serotonin Reuptake Inhibitors May Be Helpful in Most Patients With Stroke
Chollet, F. (2012) · Stroke · doi:10.1161/strokeaha.112.657619 · Cited by 4
Poststroke depression and 5-HTTLPR
Queirazza, F., & Cavanagh, J. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304149 · Cited by 3
Research works printed but not linked: 2
- Ferrari, 2016, Bioenergetic characterization of lymphocytes from stroke patients, Cerebrovascular Diseases, 41, S4
- Mandrioli, 2012, Selective serotonin reuptake inhibitors (SSRIs): Therapeutic drug monitoring and pharmacological interactions, Current Medicinal Chemistry, 19, 1846, 10.2174/092986712800099749 · doi:10.2174/092986712800099749
Cited by
Post-stroke depression: A 2020 updated review
Medeiros, G. C., Roy, D., Kontos, N., & Beach, S. R. (2020) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2020.06.011 · Cited by 587
The advances of post-stroke depression: 2021 update
Guo, J., Wang, J., Sun, W., & Liu, X. (2022) · Journal of Neurology · doi:10.1007/s00415-021-10597-4 · Cited by 400
Cheng, Y., Wang, Y., Wang, X., Jiang, Z., Zhu, L., & Fang, S. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.893097 · Cited by 110
Kiper, P., Przysiężna, E., Cieślik, B., Broniec-Siekaniec, K., Kucińska, A., Szczygieł, J., Turek, K., Gajda, R., & Szczepańska-Gieracha, J. (2022) · Clinical Interventions in Aging · doi:10.2147/cia.s375754 · Cited by 80
“On the one hand, antidepressants generate side effects that can ultimately limit the patient’s ability to take them.(10) On the other hand, access to psychotherapy can be limited.”
BackgroundEffect of Inflammation on the Process of Stroke Rehabilitation and Poststroke Depression
Fang, M., Zhong, L., Jin, X., Cui, R., Yang, W., Gao, S., Lv, J., Li, B., & Liu, T. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00184 · Cited by 66
Metadata
- Authors
- Villa, R. F., Ferrari, F., & Moretti, A.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2018-04
- Volume
- 184
- Pages
- 131-144
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2767674851
- Cited by
- 532
- References
- 201
- FWCI
- 21.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Funders
- Enrico ed Enrica Sovena Foundation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.